Ramosetron Explained

Ramosetron (INN) is a serotonin 5-HT3 receptor antagonist for the treatment of nausea and vomiting.[1] Ramosetron is also indicated for a treatment of "diarrhea-predominant irritable bowel syndrome in male and women".[2] In India it is marketed under the brand name of Ibset.

It is only licensed for use in Japan and selected Southeast Asian countries. In Japan it is sold under the trade name Irribow.[3] [4] and in India as Ibset . 'Elsewhere it is commonly sold under the trade name Nasea and in India as Nozia (150 μg/mL injection & 100 μg oral tablet).[5]

Notes and References

  1. Fujii Y, Saitoh Y, Tanaka H, Toyooka H . Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery . Anesth. Analg. . 90 . 2 . 472–5 . February 2000 . 10648342 . 10.1097/00000539-200002000-00043. free .
  2. Web site: 2008 News Releases - Astellas Pharma Inc.. www.astellas.com.
  3. http://www.qlife.jp/meds/rx13938.html Summary in Japanese
  4. Web site: 2013 News Releases Astellas Pharma Inc.. www.astellas.com. en. 2018-04-06.
  5. http://www.mims-online.com/Page.aspx?menuid=mng&name=Nasea+amp Abridged prescribing information — Nasea (MIMS Philippines)

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ramosetron".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.